This is a non-core endpoint: only basic statistics are computed.
Hepatomegaly and splenomegaly, not elsewhere classified
R18_HEPATOM_SPLENO_NOT_ELSEW_CLASSIFIED
No definition available.
Endpoint definition
↥392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
274
Check minimum number of events None
274
Include endpoints None
274
Remove individuals based on genotype QC
264
Control definitions
Extra metadata
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to Hepatomegaly and splenomegaly, not elsewhere classified based on the number of shared cases.
Broader endpoints:
- Symptoms and signs involving the digestive system and abdomen
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any event in hilmo or specialist outpatient
- Any ICDMAIN event in hilmo or causes of death
- Any prescribed medicine buy
Narrower endpoints:
None
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 264 | 125 | 139 |
Unadjusted prevalence (%) | 0.07 | 0.06 | 0.08 |
Mean age at first event (years) | 49.17 | 47.03 | 51.09 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: R18_HEPATOM_SPLENO_NOT_ELSEW_CLASSIFIED – Hepatomegaly and splenomegaly, not elsewhere classified
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Hepatomegaly and splenomegaly, not elsewhere classified
↥Endpoint not on priority list, no data to show.